2015
DOI: 10.1016/s0016-5085(15)32836-5
|View full text |Cite
|
Sign up to set email alerts
|

Tu1248 Screening for Enteric Infection in Inflammatory Bowel Disease Patients Contacting the IBD Helpline and Presenting With Disease Flares

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2016
2016
2016
2016

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(3 citation statements)
references
References 0 publications
0
3
0
Order By: Relevance
“…When looking at those studies performed in the era of biological agents, this prevalence was reduced to 2.8% (ranging from 2% to 5%). [54][55][56][57] Beyond C. difficile, C. jejuni was the most frequent isolated enteropathogen in these studies, accounting for 71% of these superinfections.…”
Section: Listeria Monocytogenesmentioning
confidence: 93%
See 2 more Smart Citations
“…When looking at those studies performed in the era of biological agents, this prevalence was reduced to 2.8% (ranging from 2% to 5%). [54][55][56][57] Beyond C. difficile, C. jejuni was the most frequent isolated enteropathogen in these studies, accounting for 71% of these superinfections.…”
Section: Listeria Monocytogenesmentioning
confidence: 93%
“…Many of the studies assessing the incidence of these infections in IBD patients come from retrospective data in the setting of clinical practice in both outpatients and inpatients. [54][55][56][57] This is somehow reflected in the European Crohn's and Colitis Organisation (ECCO) guidelines in which it is merely stated that C. difficile should be tested at every flare in patients with colonic disease, and that cytomegalovirus should be ruled out in patients with acute steroid-resistant colitis. However, the guidelines do not make any clear statements about conventional stool culture.…”
Section: Listeria Monocytogenesmentioning
confidence: 99%
See 1 more Smart Citation